Hepatitis C and injecting drug use: impact, costs and policy options

Hepatitis C may cost countries billions of EURO in healthcare

Lisbon
News release 11/2004

Download news item

PDF

PRESS AND MEDIA

Register here to receive our news releases.

Subscribe

NEWSLETTER

Register here to receive our newsletter

Subscribe

MEDIA SUPPORT

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Principal manager
Media relations and corporate communication

 Email: Kathy Robertson

 Tel: (351) 211 21 02 00/32

 Mobile. (351) 915 720 460

News

Spotlight

Laboratory showing sample tubes being tested
Drug checking data from the Trans European Drugs Information (TEDI) network
Wastewater and drugs: a European multi.city study. Animated map of Europe with coloured bubbles over maps.
Wastewater analysis and drugs — explore the latest data
EU Drug Market: Heroin and other opioids — In-depth analysis
white squares of paper with black question marks
Frequently asked questions (FAQ): drug overdose deaths in Europe
A gavel and herbal cannabis
Cannabis laws in Europe: questions and answers for policymaking
EU Drug Markets Analysis: Key insights for policy and practice
medical syringes
European Syringe Collection and Analysis Project Enterprise (ESCAPE): data and key findings
European Drug Emergencies Network (Euro-DEN Plus): data and analysis
Computer-simulated view of a virus under a microscope
Viral hepatitis elimination barometer among people who inject drugs
European Responses Guide
Top